Member Info for mugwump083

Why do marketmakers repeatedly buy or sell very small numbers of shares like 7 shares worth less than two pounds

What's happened to the open offer ? No information anywhere just seems completely incompetent. I presume it's the broker who is responsible for this incompetence.

With an asset of metals in the ground worth perhaps approximately £80 billion & allowing costs of digging it up & selling it of £20 billion there is £60 billion profit over an estimated mine life of perhaps 30 years. This averages net profit averaging £2 billion per year. On the basis of these figures it would seem insane to even think of selling out now for less that £10 billion.

Personally I would hang onto it if I owned it & organise the finance to develop it myself . That is why an analyst estimated EUA could be worth £8 per share in five years if the company itself developed the mine.

Why give away £60 billion in exchange for £10 billion or less ?

Lunacy !

Just trying to put this into a proper perspective.

Instead of the endless drivel posted here you might think some investors here would know enough about pricing mine buyouts to have informed guesses of the possible buyout price; but no, I don't see any, why not ?

How is a sale price of a mining company which owns at least £60 billion of net assets in the ground calculated ? How could a mere pound or two per share be considered an adequate price for a takeover of EUA ? At one pound per share that values those assets at about three billion or so pounds, at only two pounds per share it is only six billion.

How could we possibly give away our 60 billion pound plus net asset for only six billion pounds.

If EUA did not allow itself to be bought out but simply issued some loan notes or something to raise sufficient funds to kickstart major mine expansion, the EUA share price has already been forecast by analysts to be potentially worth £8 within five years if they just got on with the mining themselves.. That is a vastly better deal than selling out now for a pound or two per share.

I don't see many people trying to guess at what sort of realistic value EUA might have for buyer and I haven't a clue how to value a sale really . But, if I imagine that I owned EUA all myself and there are about 40 million ounces of palladium sitting in the ground waiting for me to dig it out & flog it, with today's palladium price at £1779 that is £1779 x 40 = £71,160, 000,000 of value sitting in the ground that I own. That's seventy one , one hundred & sixty thousand MILLION POUNDS or - £71,160 BILLION !

If we just guess at that being worth just about 60 billion after allowing for the costs of digging it up, then as I own all that, the question is, how much would I flog it for right now to get as much money up front as possible without all the bother of waiting to mine it myself ?

Ten per cent of the total value of £60 billion i.e £6 billion cash up front for outright sale now ? Naaaah.

Twenty percent of value up front ? That's still only £12 billion though. Doesn't sound right. I give you £60 billion in return for you giving me just £12 billion. Naaaaaaaaaah; doesn't sound fair; I want more than that. I found the stuff in the first place & it's all mine right now, and I don't see why I should allow myself to be ripped off just 'cos your bigger than me.

What do you reckon ?

HELP ! can anyone explain how to get into this idiot software to attend the webina .I'm on the right page and a button eventually appeared but then there was another page asking me if I was a shareholder and asking me to 'submit' the answer but it would not let me say yes or no to being a shareholder and therefore would not allow me to submit the info and so I can't get into the webinar.

And you wouldn't believe this, but I had a conversation with the chief executive of this software company an hour ago about this very software & how inpenatratively stupid it is. He agreed with me !!!!!!

page three

The fact AVACTA CEO Alistair Smith has planned an analyst’s meeting on Monday 28th September immediately followed by an investors meeting with an invitation to answer investor’s questions, indicates the very real probability the completion of the clinical trials are also now complete and will be announced that day too.

It would appear to me slightly bizarre if not.

page two

“Under the terms of the collaboration, LSTM will carry out the clinical validation of the Avacta COVID-19 antigen rapid saliva test in their category 3 laboratories on patient samples. In addition to working with the UK government's CONDOR programme to provide Avacta with access to patient samples in the UK, the partnership with LSTM also provides the opportunity to access patient samples in Africa and South America. The higher prevalence of the disease in those regions means that samples for prospective clinical validation studies are more readily available which, if necessary, could be used to speed up the validation process.
 
Clinical validation is the process of evaluating the performance of a diagnostic test using real patient samples. Clinical validation generates the sensitivity and specificity performance parameters which are most often used to define the performance of a diagnostic test”.
.
Only three weeks ago on 2nd September AVACTA RNS announced it had “ entered into an agreement with Abingdon Health for the manufacture of Avacta's saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity”.

The 2nd September RNS announced "Avacta, Cytiva and BBI are in the process of technology transfer of the prototype and related manufacturing procedures for the test. Avacta aims to begin clinical validation of the test as soon as possible using the first pilot batches".

"Technology transfer to Abingdon Health will begin immediately with the aim of manufacturing an equivalent rapid antigen test product which therefore does not require additional clinical validation/regulatory approvals. The agreement with Abingdon Health will provide additional manufacturing capacity that could increase to several millions of tests per month".

Dr. Alastair Smith, Chief Executive of Avacta said "The Affimer reagents that we have generated are very specific to SARS-CoV-2 antigen and we are confident of meeting and exceeding the clinical performance requirements for identifying the most infectious people”.

This timeline of the AVACTA Lateral Flow test clearly shows the final hurdle is the clinical validation of the product which has already been proved to work and is already designed ready for large scale manufacturing by the tens of millions.
This clinical validation is simply the process of using the Lateral Flow Test on a large number of real life patients to be able to document consistently successful results in the real life settings.

Once that is complete the final regulatory approval can be given to then allow AVACTA to then sell the Lateral Flow Antigen Test to anyone. This clinical validation takes about eight weeks and AVACTA have been working on this night and day since the 6th August RNS announcing the beginning of actual manufacturing. By Monday September it will be just over seven weeks since the 6th of August.

The fact AVACTA CEO Alistair Smith has planned an analyst’s meetin

page one

The AVACTA Lateral Flow Test science (the patented Afimers) has been proved by AVACTA to work & passed all initial testing. The 11th May RNS explained Avacta had provided Cytiva with these Afimers in order for Cytiva to do the donkey work of developing & designing a suitable, easy to use LFT diagnostic device which uses these Afimers.It was estimated it would 'take a few weeks' to design a prototype LFT device.

The RNS said “The Affimer reagents have now been manufactured by Avacta in the quantities required for test development and are being sent to Cytiva today. Cytiva and Avacta will now work to develop rapid test strips for the detached spike protein and for the intact virus particle, aiming to have prototype devices in a few weeks”.

On June 24th an AVACTA RNS announced “the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta's partners at Cytiva (formerly GE Healthcare Life Sciences) and show positive initial performance data”

“Following the optimisation of the lateral flow test by Cytiva the design will then be transferred to manufacturing partners in the UK that are currently being put in place by Avacta. The Company is working with these manufacturers to compress the normal manufacturing, clinical validation and regulatory timelines in order to bring a product to market as quickly as possible”.

On 6th August an AVACTA RNS announced an agreement for BBI to manufacture the LFT diagnostic device. "Cytiva and BBI are in the process of the technology transfer of the prototype and related manufacturing procedures for the saliva-based rapid SARS-CoV-2 antigen test from Cytiva to BBI", said the RNS. That is only about seven weeks ago.

AVACTA also said in the 6th August RNS that "Avacta aims to begin clinical validation of the test as soon as possible by using the first pilot batches generated as part of the technology transfer process for these studies. In parallel with these clinical validation studies, which will be run within the UK government's CONDOR programme and potentially with other collaborators globally, BBI will work with Avacta and Cytiva to produce the additional technical documentation that is required for CE marking of the final product.
On August 7th an RNS announced “Avacta and Liverpool School of Tropical Medicine collaborate to clinically validate saliva-based rapid coronavirus test being developed with Cytiva”.

“Under the terms of the collaboration, LSTM will carry out the clinical validation of the Avacta COVID-19 antigen rapid saliva test in their category 3 laboratories on patient samples. In addition to working with the UK government's CONDOR programme to provide Avacta with access to patient samples in the UK, the partnership with LSTM also provides the opportunity to access patient samples in Africa and South America. The higher prevalence of the disease in those regions means that samples for

What does S&S mean ?

If you actually had any common sense, you would realise that it might not be appropriate to rely on any inadequately tested device for passengers using aircraft. It doesn't stop the device being used in other useful ways though.

On the other hand, seeing as how passengers all over the World are currently boarding aircraft not really accurately knowing whether they have infectious Covid or not due to the total lack of adequate testing of any kind, some people might think it a bright idea to cautiously try out the new Awacta LFT test to see if it does actually work, or not, as the case may be. You might, surprise, surprise, call this tentative approach to initial use of the LFT device errrrrr....... .....VALIDATION !

If they are currently boarding aircraft effectively without any testing at all, then taking a quick ten minute LFT test isn't going to add extra potential harm should if actually not work properly. But the advice is to get a PCR test as well anyway if an LFT test shows positive.

Are people really thick or what ? The process of official validation is precisely the process of trying it out for real and using things like PCR testing to compare results to see if PCR & LFT produce results that agree, for example. And that IS what is going on at this moment. It's just all shrouded in mystique & the self importance of bureaucracy.

Hmmmmn ? Mystique & self importance; that sounds a bit like someone called Ophidian.

I wasn't able to say that Mologic took about two months to achieve validation for their antibody test, which is a good i indication of the time it might take for Awacta. So very, very soon we will have the validation results. And it is impossible in my own mind for me to be able to imagine that the Awacta LFT device has not been functioning exactly as it was designed to function and it would seem quite impossible for it to fail to be validated and released for general use.

Ophidian - I thought you were a person with the literacy to be able to read and understand what you were actually reading. I said taking the test can do no harm in itself, obviously implying by the tone of my post that that elusive thing - common sense - would have to be available in bucket loads in using this new device just it has to be available with any new thing in life until everyone is confident that the particular device has built up a past history of success. There can be no past history of success without the device being used - which is precisely what the process of validaion is.

Doh - thicko !

And as this idiotic website would not allow me to finish my post I wasn't able to say that Mologic took about two months to achieve validation for their antibody test, which is a good i indication of the time it might take for Awacta. So very, very soon we will have the validation results. And it is impossible in my own mind for me to be able to imagine that the Awacta LFT device has not been functioning exactly as it was designed to function and it would seem quite impossible for it to fail to be validated and released for general use.

I've just done a quick Google for information about exactly what is medical device validation & how long it might take. I've not had time to spend ages reading everything & organise links for here. I've been puzzled why there hasn't been the slightest explanation anywhere about this process & what it actually means.

I've also been completely gobsmacked at all the political and media panic mongering about testing and the shambolic, disorganised way the Government has organised it & total lack of honesty in explaining that PCR testing doesn't help much stopping Covid spread because it takes so long to get PCR results - days, even weeks sometimes.

I've also wondered why both media and Government haven't been able to say it looks like we will soon have saliva LFT tests because this new technology has been tested, has been scientifically VERIFIED as actually working, but now simply needs to go through the VALIDATION process which is the final entirely bureaucratic hurdle before it is allowed to be sold & released for universal use.

And all that is now needed to cheer everyone up - the politicians, the media, the business community and above all the general public, is the explanation that this VALIDATION process is purely to take a product that demonstrably works/ functions and absolutely prove beyond any doubt that when used in real life situations it will function exactly as expected every time without hiccups, design flaws, manufacturing quality etc. And that you can only do this by trying out the new LFT device on real life situations just to gather statistical evidence from a large number of times the device has been successfully (or unsuccessfully) used.

VALIDATION simply means using the new medical device (LFT) in a sufficiently large number of people and documenting that the test works reliably exactly as stated & within the various parameters claimed & carefully & precisely documenting that to build a body of irrefutable evidence that the product has now been widely used and is doing exactly what it should do in a completely reliable way.

THEN it is given official validation and allowed to flood the market freely to be used all over the World and allow economies to restart etc.

While it might be wise & appropriate for Awacta to keep very quiet about their stunning achievements so far, that does not prevent other people like the Government or the media to chatter about how bureaucracy makes it take forever (usually many years) to get approval for drugs or medical devices & perhaps sometimes a bit of common sense should be used to bypasses the mindless & plodding nature of bureaucracy when common sense sways it would be reasonably safe and appropriate.

As this saliva test can do no harm at all except theoretically giving incorrect results, common sense might suggest that while the BUREAUCRATIC VALIDATION process can happily blunder on, it can certainly be openly discussed and used really.

Take the approximate (just to simplify the maths) figure of total Global population as being seven billion people (7000 million ) . Then assume every person - all seven billion of them - uses just one AVACTA test each.
If AVACTA only make just one British pound sterling profit from each test and just rounding down AVACTA’s total shares in issue from 250.65 million to 250 million for the sake of simple maths again, that means each AVACTA share would earn £28 profit, meaning the whole 250 million AVACTA shares would earn the whole company 7000 million pounds profit - seven billion pounds !

So, every time the entire World population is tested another seven billion pounds is earned. Ideally that would be weekly testing or 52 times seven billion.
Which is 364 BILLION pounds profit per year for AVACTA.

This is just a simple illustration merely illustrating the gigantic opportunity AVACTA now has - even if only a tenth of the World population is tested. But it would be nice to think the World could, just for once, be civilised enough to make sure that every human being has access to Covid 19 testing and adequate medical care.

I've got just shy of quarter of a million shares here right now, having started buying in October at 1.98p through to 5.61 in Feb & therefore many bags in hand so far.

And if I could think of a hook to hang a story on - i.e. think of some story a publication would want to run, I'd be there like a shot. Certainly if EUA were paying me for doing their public relations, I'm sure I'd find plenty to write about.

I work for anyone who will pay me. Like most hacks have worked all, over the place; magazines, newspapers, ex sub-editor, ex magazine editor and, curiously, loads of business journalism which only goes to show just how dimwitted increasing use of silly acronyms produces so much incomprehensible, unreadable drivel - even in daily newspapers like The Times.

Many thanks; so simple to understand. I had just this moment played detective by going to the COS acquisition RNS & discovered what it meant for myself . How ludicrous to have to resort to such time consuming nonsense because of people's inability to communicate intelligently !!!